Trial Details 36 Other Sites Austin, Texas

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy

This is a global Phase III, randomized, placebo-controlled, double-blind study designed to evaluate the efficacy and safety of adjuvant treatment with atezolizumab compared with placebo in participants with MIBC who are ctDNA positive and are at high risk for recurrence following cystectomy.

Mckinney, Texas
city distance
~6 miles from Austin, Texas
facility
Texas Oncology P.A. (McKinney)
1 facility
Recruiting
Houston, Texas
city distance
~196 miles from Austin, Texas
facility
Texas Oncology - Houston (Gessner)
facility
Texas Oncology - Willowbrook
2 facilities
Recruiting
Fort Worth, Texas
city distance
~230 miles from Austin, Texas
facility
Texas Oncology-Fort Worth 12th Ave
1 facility
Recruiting
Dallas, Texas
city distance
~244 miles from Austin, Texas
facility
Texas Oncology-Medical City Dallas
1 facility
Recruiting
Denton, Texas
city distance
~277 miles from Austin, Texas
facility
Texas Oncology-Denton South
1 facility
Recruiting
McKinney, Texas
city distance
~286 miles from Austin, Texas
facility
Texas Oncology P.A. (McKinney)
1 facility
Recruiting
Pensacola, Florida
city distance
~842 miles from Austin, Texas
facility
Woodlands Medical Specialists, P.A.
1 facility
Recruiting
Littleton, Colorado
city distance
~1027 miles from Austin, Texas
facility
Rocky Mountain Cancer Center - Denver
1 facility
Recruiting
Rockledge, Florida
city distance
~1386 miles from Austin, Texas
facility
Cancer Care Centers of Brevard
1 facility
Recruiting
Las Vegas, Nevada
city distance
~1454 miles from Austin, Texas
facility
Optum Health Care
1 facility
Recruiting
Santa Barbara, California
city distance
~1759 miles from Austin, Texas
facility
Sansum Clinic
1 facility
Recruiting
Toronto, Canada
city distance
~1835 miles from Austin, Texas
facility
Princess Margaret Cancer Center
facility
Sunnybrook Research Institute
2 facilities
Recruiting
facility

Texas Oncology Cancer Center